Insulin protects against hepatocyte ultrastructural damage induced by type 1 diabetes mellitus in rats

References

• Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–40. doi:10.1016/S0140-6736(11)60679-X.
   PubMed Web of Science ®Google Scholar
• Schwarz PE, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res. 2009;41(2):86–97. doi:10.1055/s-0028-1087203.
   PubMed Web of Science ®Google Scholar
• Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34(31):2436–2443. doi:10.1093/eurheartj/eht149.
   PubMed Web of Science ®Google Scholar
• Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–188. doi:10.1152/physrev.00045.2011.
   PubMed Web of Science ®Google Scholar
• Targher G, Mantovani A, Pichiri I, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes. Diabetes Care. 2014;37(6):1729–1736. doi:10.2337/dc13-2704.
   PubMed Web of Science ®Google Scholar
• Regnell SE, Lernmark A. Hepatic steatosis in type 1 diabetes. Rev Diabet Stud. 2011;8(4):454–467. doi:10.1900/RDS.2011.8.454.
   PubMedGoogle Scholar
• Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26:19–39.
   PubMedGoogle Scholar
• Hammes HP, Feng Y, Pfister F, Brownlee M. Diabetic retinopathy: targeting vasoregression. Diabetes. 2011;60(1):9–16. doi:10.2337/db10-0454.
   PubMed Web of Science ®Google Scholar
• Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–176.
   PubMed Web of Science ®Google Scholar
• Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17(1):20–33. doi:10.1016/j.cmet.2012.11.012.
   PubMed Web of Science ®Google Scholar
• Baig NA, Herrine SK, Rubin R. Liver disease and diabetes mellitus. Clin Lab Med. 2001;21:193–207.
   PubMed Web of Science ®Google Scholar
• Smith BW, Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol. 2011;7(8):456–465. doi:10.1038/nrendo.2011.72.
   PubMed Web of Science ®Google Scholar
• Ahmadieh H, Azar ST. Liver disease and diabetes: association, pathophysiology, and management. Diabetes Res Clin Pract. 2014;104(1):53–62. doi:10.1016/j.diabres.2014.01.003.
   PubMed Web of Science ®Google Scholar
• Welt K, Weiss J, Martin R, et al. Ultrastructural, immunohistochemical and biochemical investigations of the rat liver exposed to experimental diabetes und acute hypoxia with and without application of Ginkgo extract. Exp Toxicol Pathol. 2004;55(5):331–345. doi:10.1078/0940-2993-00337.
   PubMedGoogle Scholar
• Lucchesi AN, Cassettari LL, Spadella CT. Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans. J Diabetes Res. 2015;494578:19.
   Google Scholar
• Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32–42. doi:10.1038/nrgastro.2016.147.
   PubMed Web of Science ®Google Scholar
• Evelson P, Susemihl C, Villarreal I, et al. Hepatic morphological changes and oxidative stress in chronic streptozotocin-diabetic rats. Ann Hepatol. 2005;4(2):115–120.
   PubMedGoogle Scholar
• Leite NC, Villela-Nogueira CA, Pannain VL, et al. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. Liver Int. 2011;31(5):700–706. doi:10.1111/j.1478-3231.2011.02482.x.
   PubMed Web of Science ®Google Scholar
• Verderese JP, Younossi Z. Interaction of type 2 diabetes and nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2013;7(5):405–407. doi:10.1586/17474124.2013.811047.
   PubMedGoogle Scholar
• Torbenson M, Chen YY, Brunt E, et al. Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am J Surg Pathol. 2006;30(4):508–513.
   PubMed Web of Science ®Google Scholar
• Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem. 2005;38(3):203–217. doi:10.1016/j.clinbiochem.2004.10.014.
   PubMed Web of Science ®Google Scholar
• Gomes KB. IL-6 and type 1 diabetes mellitus: T cell responses and increase in IL-6 receptor surface expression. Ann Transl Med. 2017;5(1):74. doi:10.21037/atm.2016.12.74.
   PubMed Web of Science ®Google Scholar
• Kasznicki J, Kosmalski M, Sliwinska A, et al. Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy. Mol Biol Rep. 2012;39(9):8669–8678. doi:10.1007/s11033-012-1722-9.
   PubMed Web of Science ®Google Scholar
• Chidambaram J, Carani Venkatraman A. Cissus quadrangularis stem alleviates insulin resistance, oxidative injury and fatty liver disease in rats fed high fat plus fructose diet. Food Chem Toxicol. 2010;48(8–9):2021–2029. doi:10.1016/j.fct.2010.04.044.
   PubMed Web of Science ®Google Scholar
• Dallak MA, Bin-Jaliah I, Albawardi A, et al. Swim exercise training ameliorates hepatocyte ultrastructural alterations in rats fed on a high fat and sugar diet. Ultrastruct Pathol. 2018;42(2):155–161. doi:10.1080/01913123.2017.1422581.
   PubMed Web of Science ®Google Scholar
• Sivajothi V, Dey A, Jayakar B, Rajkapoor B. Antihyperglycemic property of Tragia cannabina in streptozotocin-induced diabetic rats. J Med Food. 2007;10(2):361–365. doi:10.1089/jmf.2006.030.
   PubMed Web of Science ®Google Scholar
• Yavuz O, Cam M, Bukan N, Guven A, Silan F. Protective effect of melatonin on beta-cell damage in streptozotocin-induced diabetes in rats. Acta Histochem. 2003;105:261–266.
   PubMed Web of Science ®Google Scholar
• Lucchesi AN, Freitas NT, Cassettari LL, Marques SF, Spadella CT. Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease. Acta Cir Bras. 2013;28:502–508.
   PubMed Web of Science ®Google Scholar
• Ghanbari E, Nejati V, Khazaei M. Improvement in serum biochemical alterations and oxidative stress of liver and pancreas following use of royal jelly in streptozotocin-induced diabetic rats. Cell J. 2016;18:362–370.
   PubMed Web of Science ®Google Scholar